View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
July 21, 2022updated 26 Aug 2022 9:07am

ESG Top Trends: Technology trends

The pharma industry has deeply rooted environmental, social, and governance (ESG) issues that challenge sustainability. Overcoming these challenges requires collaborative, proactive steps to achieve sustainability goals and turn the reputation of this industry around.

Free Report
img

Thematic Research- ESG – Governance Factors

Governance is central to GlobalData’s ESG framework, developed to help companies understand and address their responsibilities across three main areas: environmental, social, and governance (ESG). Organizing the topic into these three key areas makes it easier for companies to assess where they stand. The framework goes deeper and defines four key areas within each topic. Within corporate governance, these are corporate structure, risk management, corruption, and bribery and ethics. Then, within each area, the framework identifies several contributing factors and mitigating actions to help companies identify where progress is needed and create action plans. Good corporate governance has never been more important. It has come to the fore as directors and executives recognize that they are responsible not just to shareholders, as in the past, but to a wide range of stakeholders. GlobalData’s report on ESG - Governance Factors, taken from the collection of >17,000 reports on GlobalData Explorer, will help you to:    
  • Assess companies based on GlobalData’s detailed ESG framework on governance
  • Identify relevant issues pertaining to governance using our framework
  • Explore reasons why governance is an important ESG issue
  • Identify factors which help to improve corporate governance in a company
Don’t miss out on key market insights that can help optimize your next investment – read the report now.
by GlobalData
Enter your details here to receive your free Report.

Listed below are the key technology trends impacting the ESG performance in the healthcare sector, as identified by GlobalData.

Artificial intelligence (AI)

Pharma and medical device companies are implementing AI to transform supply chains and better manage their operations. With predictive analytics, AI provides increased visibility of supply chains, improving transparency around costs, logistics, warehousing, and inventory. Data are collected from each stage and then analysed by AI algorithms to increase efficiency and productivity.

AI also speeds up the drug development process, which could translate into cheaper drugs for patients. BenevolentAI is exploring AI for disease modification across weeks rather than months. Additionally, AI can improve patient wellbeing by automating health records, predicting illness, and enhancing treatment efficiency.

3D printing

For pharma and medical device companies, 3D printing can reduce costs, waste, and the environmental burden. Aprecia Pharmaceuticals’ Spritam, an anti-epileptic drug, is the first and only 3D-printed pharmaceutical, having received US Food and Drug Administration (FDA) approval in 2015. While large pharma companies have been slow in this area, Merck and GSK are now using 3D printing for clinical trials and manufacturing. Orthopaedic companies have been using 3D printing for their implants for years.

3D bioprinting offers an alternative to animal testing in drug development. 3D tissues provide a far more accurate representation of reality, resulting in more predictive findings for drug candidates and reduced late-stage failures.

Cybersecurity and ESG

The healthcare industry is vulnerable to cyberattacks due to the amount of valuable and sensitive data it produces. During the pandemic, there have been numerous cyberattacks on hospitals and institutions, especially those associated with Covid-19 research. This is demanding stronger investments in cybersecurity across the industry. There is also increased risk of cybersecurity attacks since the start of the Ukraine invasion, with companies and healthcare systems on high alert.

Telemedicine poses significant privacy and security issues. Staff must be trained on processes and systems and patients made aware of security best practices. Blockchain can mitigate cybersecurity risks by preventing unauthorised access to assets such as networks and clinical data, ensuring systems are efficient for healthcare professionals and patients.

This is an edited extract from the ESG (Environmental, Social, and Governance) Top Trends by Sector – Thematic Research report produced by GlobalData Thematic Research.

Related Companies

Free Report
img

Thematic Research- ESG – Governance Factors

Governance is central to GlobalData’s ESG framework, developed to help companies understand and address their responsibilities across three main areas: environmental, social, and governance (ESG). Organizing the topic into these three key areas makes it easier for companies to assess where they stand. The framework goes deeper and defines four key areas within each topic. Within corporate governance, these are corporate structure, risk management, corruption, and bribery and ethics. Then, within each area, the framework identifies several contributing factors and mitigating actions to help companies identify where progress is needed and create action plans. Good corporate governance has never been more important. It has come to the fore as directors and executives recognize that they are responsible not just to shareholders, as in the past, but to a wide range of stakeholders. GlobalData’s report on ESG - Governance Factors, taken from the collection of >17,000 reports on GlobalData Explorer, will help you to:    
  • Assess companies based on GlobalData’s detailed ESG framework on governance
  • Identify relevant issues pertaining to governance using our framework
  • Explore reasons why governance is an important ESG issue
  • Identify factors which help to improve corporate governance in a company
Don’t miss out on key market insights that can help optimize your next investment – read the report now.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology